ch.oddb.org
 
Apotheken | Arzt | Interaktionen | Medikamente | MiGeL | Services | Spital | Zulassungsi.
Fachinformation zu Levovist®:Bayer (Schweiz) AG
Vollst. FachinformationDDDDrucken 
Zusammens.Galen.FormInd./Anw.mögl.Dos./Anw.Kontraind.Warn.hinw.Interakt.Schwangerschaft
Fahrtücht.Unerw.WirkungenÜberdos.Eigensch.Pharm.kinetikPräklin.Sonstige H.Swissmedic-Nr.
Reg.InhaberStand d. Info. 
V08DA02 - Microparticles Of GalactoseATC-DDD Version 2016. Source: WHO
V - Various
 

This group comprises many different types of drugs, and assigning DDDs are difficult. Very few DDDs are assigned in this group.

V08 - Contrast Media

This group comprises X-ray, MRI and Ultrasound contrast media. The X-ray contrast media are subdivided into iodinated and non-iodinated compounds, and are further classified according to water solubility, osmolarity and nephrotropic/hepatotropic properties. High osmolar substances correspond mainly to ionic substances, except from ioxaglic acid, which is classified together with the non-ionic substances. MRI contrast media are subdivided according to magnetic properties.

V08D - Ultrasound Contrast Media
 
V08DA - Ultrasound Contrast Media

The microspheres may contain various ingredients. E.g. perflutren suspension in microspheres of phospholipids is classfied in V08DA04.
Perflenapent covers structural isomers of dodecafluoropentane i.e. perflisopent.

V08DA02 - Microparticles Of Galactose
2024 ©ywesee GmbH
Einstellungen | Hilfe | FAQ | Anmeldung | Kontakt | Home